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NADPH-cytochrome c (P-450) reductases from horse placenta nd rat liver were purified and their biological activities compared using cytochrome 
c as substrate. Rat liver reductase was purified to electrophoretic homogeneity in one chromatographic step on 2’,5’-ADP agarose, and had a relative 
mass of 85 000 Da as estimated by SDS-PAGE. Equine placental reductase was separated from cytochrome P-450 on aminohexyl-Sepharose 4B 
and further purified on 2’,5-ADP agarose; this preparation exhibited two bands, one of 85 000 and one of 80 000 Da, on SDS-PAGE. The lower 
molecular weight form was assumed to be a proteolytic product of the higher molecular weight form. A high retention of activity was obtained 
in both preparations. Equine placenta and rat liver enzymes were found to exhibit very similar V,,, and K,, suggesting that they are not species 
specific. 
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1. INTRODUCTION 
Estrogen biosynthesis is catalyzed by a microsomal 
mixed-function oxidase system termed estrogen syn- 
thetase (EC 1.14.14.1). This enzyme complex includes 
NADPH-cytochrome c (P-450) reductase and cyto- 
chrome P-450. In the human, Cl9 androgens (an- 
drostenedione, testosterone and 16a-hydroxytestos- 
terone) are far more rapidly aromatized than are 
1Pnorandrogens [l-3]. In contrast, we have shown 
that mare placental estrogen synthetase is able to 
aromatize 1Pnorandrogens and androgens in vitro with 
approximately the same rate [4]. These observations, 
together with our previous findings on equine testicular 
and ovarian aromatases [5,6], indicate that equine 
aromatase is species specific and differs from the 
human model. 
hibited androstenedione aromatization by human, ba- 
boon and horse placental microsomes with different 
efficiencies [9]. However, the biochemical properties of 
horse placental NADPH-cytochrome c (P-450) reduc- 
tase have not previously been studied. To investigate 
whether this component of the equine placental 
aromatase complex exhibits or not such specific 
characteristics in comparison to the widely used rat 
liver enzyme, we decided to purify NADPH- 
cytochrome c (P-450) reductases from horse placenta 
and phenobarbital-treated rat liver, and to compare the 
reductase activities of these enzymes using horse heart 
cytochrome c as substrate. 
2. MATERIALS AND METHODS 
2.1 Chemicals 
There is general agreement that the substrate 
specificity of mixed-function oxidases is determined by 
the cytochrome P-450 moiety, and that NADPH- 
cytochrome c (P-450) reductase is common to all 
cytochromes P-450. However, immunological and/or 
chemical differences between NADPH-cytochrome c 
(P-450) reductases from different tissues or species 
have been reported, thus suggesting a tissular and/or 
species specificity of the enzyme [7,8]. 
NADP + , NADPH, cytochrome c (equine heart), dilauroyl- 
phosphatidylcholine, FAD, FMN, Chaps 2’ ,5 ’ -agarose, aminohexyl- 
Sepharose 4 B, sodium cholate, Lubrol and concanavalin A were pur- 
chased from Sigma Chemical Co. Pharmacia Fine Chemicals sup- 
plied the 2’ ,5 ‘-ADP agarose resin. Biobeads and chemicals employed 
for SDS-PAGE were from Bio-Rad. [l&‘H]Androstenedione was 
obtained from NEN. Other chemicals and solvents were from Sigma 
or Merck. 
2.2. Animals and preparation of microsomes 
Osawa et al. reported that antibody against human 
placental NADPH-cytochrome c (P-450) reductase in- 
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Six Sprague-Dawley male rats (300 g) were injected in- 
traperitoneally with a 4% (w/v) solution of phenobarbital in 0.9% 
NaCl at a dose of 40 mg/kg daily for 5 days. Full-term placenta from 
a thoroughbred mare was collected immediately after delivery and 
processed as described previously [4]. Microsomes from equine 
placenta and rat liver were prepared according to the same method 
[4]. Rat liver microsomes were resuspended in 0.01 M sodium 
fiblished by Elsevier Science Publishers B. V. (Biomedical Division) 
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phosphate buffer, pH 7.4, containing 20% glycerol, 1 mM EDTA 
and 1 mM dithiothreitol (Buffer A) to a final protein concentration 
of 27.2 mg/ml. Equine placental microsomes were resuspended in 
0.05 M sodium phosphate buffer, pH 7.4, containing 20% glycerol, 
100 mM KCI, 1 mM EDTA, 1 mM dithiothreitol, 5 mg/l butylated 
hydroxytoluene and 2 CM androstenedione (Buffer B), to a final pro- 
tein concentration of 28.9 mg/ml. 
2.3. Protein determination 
Protein concentrations were assayed with the Biorad dye-binding 
assay, using serum bovine albumin as standard. 
2.4. Envme assays 
Reductase activity was determined by measuring the reduction of 
cytochrome c at 550 nm. Incubations were performed at 30°C in 2.5 
ml of 0.2 M sodium phosphate buffer, pH 7.5, containing 0.4 mM 
KCN, 0.04 mM EDTA, 0.04 mM NADPH and 20 pM cytochrome c. 
A molecular extinction coefficient of 19 mM - ’ .crn- ’ was used. In 
the kinetic study versus cytochrome c concentration (2-40pM), in- 
cubations were at 25°C for 5 min in 2.5 ml of 0.2 M sodium 
phosphate buffer, pH 7.5, containing 0.04 mM EDTA, 0.04 mM 
NADPH and 20% glycerol. 
Aromatase activity was determined by measuring the release of 
tritium from [lp-3H]androstenedione. Incubations were in 0.5 ml of 
0.05 M Tris-maleate buffer, pH 7.4, containing ethylene glycol(3%), 
dilauroylphosphatidylcholine (40 &g/ml), 0.25 units of purified rat 
liver NADPH-cytochrome c (P-450) reductase, and 200 nM 
substrate. Reaction was initiated by the addition of 0.3 mM NADPH 
and stopped with 2 ml chloroform. Samples were then processed as 
described previously [4]. In all assays, except for tests for aromatase 
activity in elution fractions, detergents were extracted using Biobeads 
(40 mg/ml) with stirring for 1 h at 4°C. 
2.5. Solubilization and purification of equine placental NADPH- 
cytochrome c (P-450) reductase and partial purification of 
cytochrome P-450 
Equine placental microsomes were diluted with Buffer B and a 
10% Chaps solution was added dropwise to a final concentration of 
2.3% Chaps and a final protein concentration of 13 mg/ml. 
Microsomes were stirred for 30 min at 4°C and centrifuged for 1 h 
at 120 000 x g. The supernatant (76 ml) was diluted with 20 mM 
sodium phosphate buffer, pH 7.4, containing 20% glycerol, 1 mM 
dithiothreitol, 0.2 mM EDTA, 2 CM androstenedione and 0.3% 
Chaps (Buffer C), to a final volume of 750 ml. The mixture was 
pumped (35 ml/h) directly to an aminohexyl-Sepharose 4B column 
(2.6x 14 cm) previously equilibrated with 200 ml of Buffer C ac- 
cording to the method of Tan and Muto [lo]. The column was wash- 
ed with 450 ml of Buffer C and then eluted with a linear gradient of 
NaCl (0 to 1 M) in Buffer C. The eluted fractions were collected and 
assayed for cytochrome c reduction and aromatase activities. The 
fractions with reductase activity were pooled (97.5 ml), dialyzed for 
18 h against 0.1 M sodium phosphate buffer, pH 7.7, containing 
0.4% sodium cholate, 0.1 mM EDTA, 0.1 mM dithiothreitol, 20 pM 
butylated hydroxytoluene, 5 pM FMN and 20% glycerol, and then 
applied directly to a 2’,5 ‘-ADP agarose column (2.5 x 4 cm) at a 
flow rate of 1 ml/min according to the procedure of Ardies et al. [ll]. 
The active fractions were pooled and dialyzed on Sephadex G25 (PD 
10, Pharmacia) to remove NADP +, and stored at -20°C. The frac- 
tions eluted from the aminohexyl-Sepharose 4Bcolumn and contain- 
ing aromatase activity were pooled (75 ml) and applied to a 
ConA-Sepharose 4B column (1.6 x 12 cm) previously equilibrated 
with Buffer C. The column was washed with 300 ml of Buffer C con- 
taining 1 M NaCl and then eluted with Buffer C containing 1 M 
NaCl, 0.05% Emulgen 913 and 0.2 M methyl a-D-mannoside. The 
eluted fractions containing aromatase activity were pooled, dialyzed 
against 0.01 M sodium phosphate buffer, pH 7.4, containing 20% 
glycerol, 0.1 Vo Nonidet P 40, 0.1 mM EDTA, 0.1 mM dithiothreitol 
and 2 pM androstenedione, and stored at -20°C. These preparations 
remained stable for several weeks when stored at -20°C. 
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2.6. Solubilization and purification of rat liver NADPH-cytochrome 
c (P-450) reductase 
Rat liver microsomes were diluted to about 18 mg protein/ml with 
Buffer A and solubilized by dropwise addition of a 10% (w/v) solu- 
tion of Chaps to a final concentration of 2% and a final protein con- 
centration of 9.5 mg/ml. After stirring for 30 min at 4”C, 
microsomes were centrifuged (120 000 x g, 1 h). Purification was 
carried out as described above for equine placental NADPH- 
cytochrome c (P-450) reductase using a 2’ ,5 ’ -ADP agarose column 
(2.5 x 4 cm). This preparation was stable for several weeks when 
stored at -20°C. 
2.7. Gel electrophoresis 
SDS-PAGE was performed using 12% gels according to the 
method of Laemmli 1121. 
2.8. Spectral study 
The flavin content of reductase preparations was measured with a 
dual beam Perkin-Elmer spectrophotometer (Lambda 15), using an 
extinction molecular coefficient of 10.7 mM - ‘. cm - I. 
3. RESULTS AND DISCUSSION 
Use of the zwitterionic detergent, Chaps, resulted in 
an effective solubilization of equine placental 
cytochrome P-450 and of both equine placental and rat 
liver NADPH-cytochrome c (P-450) reductases with an 
increase in their specific activities. Sodium cholate 
anionic detergent was not used for solubilization since 
a deleterious effect on cytochrome P-450 activity was 
observed during storage (data not shown); this observa- 
tion is consistent with the results of Nakajin et al. [13] 
who reported that purified human placental 
cytochrome P-450arom had a half-life of only 2.5 days 
when stored at -80°C in a buffer containing small 
amounts of Emulgen and sodium cholate. 
The total recovery for purification of rat liver en- 
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Fig. 1. Aminohexyl-Sepharose-4B chromatography of the solubilized 
fraction of equine placental microsomes. The solubilized fraction, 
obtained by incubation of microsomes with 2.3% Chaps at 4°C for 
30 min, was applied to an aminohexyl-Sepharose 4B column (2.6 x 
14 cm), and eluted with a linear gradient of NaCl (0 to 1 M). 10 pl 
of each elution fraction (8 ml) was assayed for reductase and 
aromatase activities. Details of the chromatographic procedure and 
biological activity assays are given in section 2. 
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Table 1 
Purification of equine placental NADPH-cytochrome c (P-450) reductase 
Proteins Total activity Specific activity Yield 
(mg) (umol/min) (crmol/min/mn) (%f 
Purification 
fold 
Microsomes 1300 325 0.25 LOO 
Solubilized supernatant 758 349 0.46 107 1.8 
Aminoh~yl-~ph~ose 4B 63 189 3 58 12 
2’ ,S’-ADP agarose 4.35 174 40 54 160 
Reductase activity was assayed at 3O“C in 0.2 M sodium phosphate buffer, pH 7.5. 
zyme (75olo) was comparable to that reported by Ardies 
et al. [l 11. The specific activity found in microsomes 
(0.36 units/mg protein) was brought to 25 units/mg 
protein in the purified preparation. 
Fig.1 shows that a clean separation of equine 
NADPH-cytochrome c (P-450) reductase from cyto- 
chrome P-450 was obtained by chromatography on 
aminohexyl-Sepharose 4B, confirming the results of 
Tan and Muto [lo]. Tables 1 and 2 summarize the 
results of the purification procedure of equine placental 
enzymes. The 2’ ,5’-ADP agarose chromatography 
step resulted in the greatest increase in purity and 
specific activity of the reductase. The yield for equine 
placental enzyme was lower (54%), due to the 
~inohexyl-Sepharose 4B step. A high purification fac- 
tor (X 160) was obtained for the equine placental en- 
zyme; the smaller value ( x 70) obtained for the rat liver 
enzyme, although comparable to that reported by Ar- 
dies et al. [1 I], could be related to the high bulk of en- 
zyme present in the liver of rats treated with 
phenobarbital. 
The results of the analysis of equine placental and rat 
liver NADPH-cytochrome c (P-450) reductases by 
SDS-PAGE are shown in fig.2. Rat liver enzyme ex- 
hibited a single band corresponding to a molecular 
mass of 85 000, indicating the efficiency of the one step 
purifi~tion on 2’ ,5’ ADP-agarose affinity column. 
Equine placental enzyme was resolved into two bands 
corresponding to molecular masses of 80 000 and 
85 000. Vermilion and Coon [14] have reported that the 
native enzyme can be converted by trypsin to a smaller 
protein by loss of a 5 000-6 000 hydrophobic 
membrane-binding part of the protein [15]; the lower 
band obtained for equine placental enzyme could 
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Fig.2. SDS-PAGE of equine placental and rat liver reductases. The 
proteins were treated with 2.4010 SDS and 5% ~-mer~ptoethanol at 
100°C for 5 min and subjected to electrophoresis on a 12% 
polya~ylamide gel. Gels were stained with Coomassie blue. (Lanes A 
and B) 20 r(g (A) and 10 pg (B) of rat liver enzyme. (Lane D and E) 
40 pg and 20 pg of equine placental enzyme. (Lane C) Molecular mass 
markers dbtained from Bio-Rad consisted of rabbit muscle 
phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), hen 
egg white ovalbumin (42.7 kDa), bovine carbonic anhydrase (31.1 
kDa), soybean trypsin inhibitor (21.5 kDa), hen egg white lysozyme 
(14.4 kDa). 
Microsomes 
Solubilized supernatant 
Aminohexyl-Sepharose 
Table 2 
Partial purification of equine placental cytochrome P-450 
Proteins Total activity Specific activity Yield Purification 
(mg) (nmo~/min) (pmol/min/mg) (@Jo) fold 
1300 110.1 84.7 loo 
757 105.1 138.7 95.5 1.6 
64.2 15.6 242.5 14 2.8 
Con A 6.1 5 828.i 4.6 9.8 
Aromatase activity was assayed at 20°C in 0.05 M Tris-maleate buffer, pH 7.4, using 0.25 units of purified rat liver NADPH-cytochrome P-450 
reductase. 
33 
Volume 261, number 1 FEBS LETTERS February 1990 
therefore result from proteolysis of the native enzyme. 
If the upper band can be assumed to be the native 
NADPH-cytochrome c (P-450) reductase, the molec- 
ular weights of equine placental and rat liver enzymes 
found in the present study would be identical and com- 
parable to those reported for human placental [9] or 
house flies [16] enzymes. However, it is to be noted that 
a range of values extending from 72 000 to 83 000 can 
be found in the literature [7,11,14,17-201; the reasons 
for this variance are not known. Coon et al. [21], who 
compared the use of Renex 690 or deoxycholate for the 
solubilization of rat liver enzyme noted a variation in 
electrophoretic mobility corresponding to a difference 
of 2 000 in the molecular weights obtained by 
SDS-PAGE. 
The flavin content of the rat liver enzyme (1.3 mol 
flavin/mol enzyme) was comparable to values reported 
elsewere [ 14-171. The absorption spectrum of the 
equine placental enzyme was that of a flavoprotein with 
peaks at 380 nm and 454 nm. The flavin content was 
found to be 1.8 mol flavin/mol enzyme, and was in the 
same range as the values reported in most publications 
for rat liver [14,17], swine testis [18], and house fly [la] 
enzymes. Incubations of both enzyme preparations (1 h 
at 4°C) with lOO-fold concentrations of FMN and 
FAD, followed by dialysis on Sephadex G25 (PD 10, 
Pharmacia) did not modify the original flavin content, 
indicating a good fixation of the flavin on the purified 
proteins. 
High cytochrome c reductase activities have been 
reported for both the small and high molecular weight 
forms of the reductase [7,15]. Moreover, Bellino [22] 
reported that both forms of the human placental en- 
zyme exhibited very similar K,,, for cytochrome c and 
NADPH. These results prompted us to use cytochrome 
c as substrate to compare our two purified reductases. 
As shown by double reciprocal plots, V,,, of horse 
placental NADPH-cytochrome c (P-450) reductase (1.4 
units/mm01 flavin) was similar to that of rat liver en- 
zyme (1.36 units/mm01 flavin). The Km value of the 
horse placental enzyme (8.2 ,uM cytochrome c) and of 
the rat enzyme (13.5 ,uM cytochrome c) were of the 
same order of magnitude. 
It would thus seem that these enzymes are not species 
specific. This is in apparent disagreement with the 
findings of Osawa et al. [9] who reported that antibody 
against NADPH-cytochrome c (P-450) reductase from 
human placenta suppressed cytochrome c reduction ac- 
tivity of human, baboon and horse purified reductases 
with different efficiencies, thus suggesting a species 
specificity. Nevertheless, immunological differences 
between enzymes may not necessarily be correlated to 
biological specificity, i.e. reductases from different 
sources (species, tissues) could contain different an- 
tigenic determinants corresponding to parts of the en- 
zyme not involved in catalysis or binding, thus resulting 
in immunological but not biochemical differences with 
regard to the reduction of cytochrome c. It must be 
noted that the similarity in behaviour we observed be- 
tween the rat liver and equine placental reductases with 
cytochrome c as a substrate does not exclude the 
possibility of differences between other properties of 
these two enzymes. 
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